These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 8919323

  • 1. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs.
    Maes M, De Meester I, Scharpe S, Desnyder R, Ranjan R, Meltzer HY.
    Acta Psychiatr Scand; 1996 Jan; 93(1):1-8. PubMed ID: 8919323
    [Abstract] [Full Text] [Related]

  • 2. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs.
    Maes M, Goossens F, Scharpé S, Calabrese J, Desnyder R, Meltzer HY.
    Psychiatry Res; 1995 Oct 16; 58(3):217-25. PubMed ID: 8570777
    [Abstract] [Full Text] [Related]

  • 3. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers.
    Maes M, De Meester I, Verkerk R, De Medts P, Wauters A, Vanhoof G, Vandoolaeghe E, Neels H, Scharpé S.
    Psychoneuroendocrinology; 1997 Feb 16; 22(2):65-78. PubMed ID: 9149329
    [Abstract] [Full Text] [Related]

  • 4. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A, Fouilloux C, Ortiz S.
    Proc West Pharmacol Soc; 2002 Feb 16; 45():154-5. PubMed ID: 12434564
    [No Abstract] [Full Text] [Related]

  • 5. Lower serum activity of prolyl endopeptidase in fibromyalgia is related to severity of depressive symptoms and pressure hyperalgesia.
    Maes M, Libbrecht I, Van Hunsel F, Lin AH, Bonaccorso S, Goossens F, De Meester I, De Clerck L, Biondi M, Scharpe S, Janca A.
    Psychol Med; 1998 Jul 16; 28(4):957-65. PubMed ID: 9723150
    [Abstract] [Full Text] [Related]

  • 6. Prolyl endopeptidase and dipeptidyl peptidase IV are associated with externalizing and aggressive behaviors in normal and autistic adolescents.
    Frenssen F, Croonenberghs J, Van den Steene H, Maes M.
    Life Sci; 2015 Sep 01; 136():157-62. PubMed ID: 26165750
    [Abstract] [Full Text] [Related]

  • 7. Antidepressant usage in schizophrenia.
    Plasky P.
    Schizophr Bull; 1991 Sep 01; 17(4):649-57. PubMed ID: 1687176
    [Abstract] [Full Text] [Related]

  • 8. Drug-responsive symptoms during early neuroleptic treatment.
    Mazure CM, Nelson JC, Jatlow PI, Bowers MB.
    Psychiatry Res; 1992 Feb 01; 41(2):147-54. PubMed ID: 1574541
    [Abstract] [Full Text] [Related]

  • 9. [Antidepressant treatment of schizophrenic patients].
    Caroli F, Baldacci-Epinette C, Ribeyre P.
    Encephale; 1993 Jul 01; 19 Spec No 2():393-6. PubMed ID: 7904237
    [Abstract] [Full Text] [Related]

  • 10. Effects of psychological stress on serum prolyl endopeptidase and dipeptidyl peptidase IV activity in humans: higher serum prolyl endopeptidase activity is related to stress-induced anxiety.
    Maes M, Goossens F, Lin A, De Meester I, Van Gastel A, Scharpé S.
    Psychoneuroendocrinology; 1998 Jul 01; 23(5):485-95. PubMed ID: 9802123
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ, Samson JA, Bessette MP, Carter-Campbell JT.
    J Clin Psychiatry; 1993 Sep 01; 54(9):338-42. PubMed ID: 8104930
    [Abstract] [Full Text] [Related]

  • 12. Identification of altered dipeptidyl-peptidase activities as potential biomarkers for unipolar depression.
    Deng J, Lamb JR, Mckeown AP, Miller S, Muglia P, Guest PC, Bahn S, Domenici E, Rahmoune H.
    J Affect Disord; 2013 Nov 01; 151(2):667-672. PubMed ID: 23948634
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.
    Frommberger UH, Bauer J, Haselbauer P, Fräulin A, Riemann D, Berger M.
    Eur Arch Psychiatry Clin Neurosci; 1997 Nov 01; 247(4):228-33. PubMed ID: 9332905
    [Abstract] [Full Text] [Related]

  • 14. Decreased serum dipeptidyl peptidase IV activity in major depression.
    Maes M, De Meester I, Vanhoof G, Scharpé S, Bosmans E, Vandervorst C, Verkerk R, Minner B, Suy E, Raus J.
    Biol Psychiatry; 1991 Sep 15; 30(6):577-86. PubMed ID: 1681947
    [Abstract] [Full Text] [Related]

  • 15. Treating depression in schizophrenia.
    Lund BC, Perry PJ, Miller DD.
    Am J Psychiatry; 2001 Sep 15; 158(9):1528-9. PubMed ID: 11532750
    [No Abstract] [Full Text] [Related]

  • 16. Do neuroleptics cause depression?
    Roy A.
    Biol Psychiatry; 1984 May 15; 19(5):777-81. PubMed ID: 6145454
    [Abstract] [Full Text] [Related]

  • 17. Cyproheptadine in treatment-resistant chronic schizophrenics with prior negative response to fluoxetine.
    Bacher NM, Sanzone MM, Kaup B.
    J Clin Psychopharmacol; 1994 Dec 15; 14(6):424-5. PubMed ID: 7884024
    [No Abstract] [Full Text] [Related]

  • 18. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
    Maes M, Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Meltzer H.
    Mol Psychiatry; 2001 Jul 15; 6(4):475-80. PubMed ID: 11443537
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis.
    Helfer B, Samara MT, Huhn M, Klupp E, Leucht C, Zhu Y, Engel RR, Leucht S.
    Am J Psychiatry; 2016 Sep 01; 173(9):876-86. PubMed ID: 27282362
    [Abstract] [Full Text] [Related]

  • 20. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP.
    Encephale; 1998 Jul 01; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.